Editorial Board
Yusuf TUTAR PhD
University of Health Sciences · Turkey
Editorial leadership for International Journal of Translational Research
Research interests
- Molecular Cancer Research
- Epigenetic (Rt-Pcr
- Microarray). Microrna
- Pseudogenes
- And Transfection. Prion
- Translation Termination In Eukaryotes
- And Transcription Initiation In Prokaryotes. Investigating Structure-Function Relationship Of Biological Macromolecules With Biochemical
- Biophysical
- Genetics
- Molecular Biological Methods. Recombinant Dna Technology
- Molecular Sub-Cloning
- Transformation
- Protein Expression. Drug Design
- Docking
- Molecular Dynamics. Nanoparticles For Drug Targeting. Protein Purification (Heat Shock
- Catabolite Repressor
- S100P Proteins)
- Characterisation (Spectroscopy: Fluorescence
- Luminescence
- Cd
- Ftir; Calorimetry: Nanodsc
- Itc; Chromatography: Hplc
- Fplc; Other Techniques: Maldi-Tof
- Gc
- Spr)
Biography
- Dr. Yusuf TUTAR is the Head of Biochemistry Division and the Head of Basic Sciences Department at Faculty of Pharmacy, Cumhuriyet University, Sivas Turkey.
- Dr. Tutar is also the Head of Biomedical Engineering Program at the same university.
- He obtained his M.Sc. and Ph.D. at Oregon State University and Texas Tech University respectively.
- He pursued his postdoctoral study at National Institutes of Health (NIH/NIDDK), USA.
- His research focuses on Biochemistry, Biophysics, Genetics, and Molecular Biology with specialization in the fields of protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.
- Dr. TUTAR is currently faculty at Health Sciences University, Istanbul.
Selected publications
- Performance of capecitabine in novel combination therapies in colorectal cancer 2021 cited 17×
- Triad pyrazole–thiazole–coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis 2023 cited 14×
- Perturbation of HSP Network in MCF-7 Breast Cancer Cell Line Triggers Inducible HSP70 Expression and Leads to Tumor Suppression 2020 cited 13×
- Designing Specific HSP70 Substrate Binding Domain Inhibitor for Perturbing Protein Folding Pathways to Inhibit Cancer Mechanism 2021 cited 8×
- Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics 2024 cited 8×
- In Vitro Effects of Rumex confertus Extracts on Cell Viability and Molecular Pathways in MCF-7 Breast Cancer Cells Recent 2025 cited 6×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJTR for your work?
This journal is guided by Yusuf TUTAR (University of Health Sciences) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.